Balance Sheet for Arrowhead Pharmaceuticals Inc. (ARWR)

$ 38.49   -1.25 (-3.15%) Volume: 1.06m 4:00 PM EST 21-Feb-2020
After Hours:  $ 39.03   0.54 (+1.40%) Volume: 18.26k 7:48 PM EST 21-Feb-2020
Statement: View:
Assets [+] in Thousands of Dollars
09/2019 09/2018 09/2017 09/2016 09/2015
Cash and Equivalents 221,804 30,133 24,839 85,366 81,214
Restrictable Cash 1,000 - - - -
Marketable Securities 36,900 46,400 40,770 - 17,540
Accounts Receivable 661 327 68 75 -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 661 327 68 75 -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 3,318 1,268 867 1,290 3,293
Current Deferred Income Taxes - - - - -
Other Current Assets 2,563 640 1,360 3,771 824
Total Current Assets 265,247 78,769 67,903 90,503 102,871
Land and Improvements - - - - -
Buildings and Improvement 21,579 12,236 12,208 11,885 3,118
Machinery, Furniture and Equipment 13,717 11,505 10,393 8,014 6,870
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 35,297 23,741 22,602 19,900 9,988
Gross Fixed Assets 35,297 23,741 22,602 19,900 9,988
Accumulated Depreciation (12,082) (9,805) (7,089) (4,513) (5,461)
Net Fixed Assets 23,215 13,935 15,513 15,387 4,527
Intangibles 17,064 18,764 20,464 22,165 24,824
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 144 142 142 122 46
Total Non-Current Assets 84,599 32,841 36,119 37,674 29,397
Total Assets 349,845 111,610 104,022 128,177 132,268
Liabilities [+] in Thousands of Dollars
09/2019 09/2018 09/2017 09/2016 09/2015
Accounts Payable 7,650 2,806 4,077 12,233 5,032
Short Term Debt - 224 209 194 218
Notes Payable - - - - -
Accrued Expenses 11,461 8,981 7,964 8,557 9,200
Accrued Liabilities 11,461 8,981 7,964 8,557 9,200
Deferred Revenues 77,770 1 5,270 2,570 103
Current Deferred Income Taxes - - - - -
Other Current Liabilities 191 354 1,182 2,090 1,348
Total Current Liabilities 97,071 12,365 18,701 25,644 15,901
Long Term Debt - 2,101 2,325 2,533 541
Deferred Income Tax 8,739 1,703 1,929 4,775 142
Other Non-Current Liabilities 8,739 1,903 2,129 4,975 6,205
Minority Interest (555) (555) (555) (555) (555)
Capital Lease Obligations - - - - 541
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 8,183 3,449 3,899 6,953 6,191
Total Liabilities 105,254 15,814 22,600 32,597 22,091
Preferred Shareholder's Equity - - - 0 0
Common Shareholder's Equity 244,591 95,796 81,422 95,579 110,177
Common Par 188 181 167 162 152
Additional Paid in Capital 664,086 582,903 514,037 493,845 426,873
Cumulative Translation Adjustments - - - - -
Retained Earnings (419,291) (487,266) (432,815) (398,435) (316,712)
Treasury Stock - - - - -
Other Equity Adjustments (392) (22) 33 7 (136)
Total Capitalization 244,591 97,897 83,747 98,113 110,177
Total Equity 244,591 95,796 81,422 95,579 110,177
Total Liabilities & Shareholder's Equity 349,845 111,610 104,022 128,177 132,268
Cash Flow 67,975 (54,450) (34,380) (81,723) (91,938)
Working Capital 168,176 66,404 49,202 64,859 86,971
Free Cash Flow 161,034 (48,645) (31,857) (68,288) (67,678)
Invested Capital 244,591 97,897 83,747 98,113 110,177
Shares Outstanding - Common Class Only 95,506 88,505 74,785 69,747 59,545
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 95,506 88,505 74,785 69,747 59,545
Total Common Shares Outstanding 95,506 88,505 74,785 69,747 59,545
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 93,859 83,638 73,899 61,051 57,358
Diluted Weighted Shares Outstanding 98,608 83,638 73,899 61,051 57,358